Insulin-dependent transmembrane glucose transport in cardiovascular disease

Journal of Clinical and Basic Cardiology

Volumn 9, Issue 1-4, 2006, Pages 1-3

  Gasser, S ^a   Scherr, E ^a   Friehs, I ^b   Gasser, Robert ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Glucose; GLUT4; Insuline; Myocardial

Indexed keywords

COMPLEMENTARY DNA; GLUCOSE TRANSPORTER 4; ION CHANNEL; MESSENGER RNA;

CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; ENERGY METABOLISM; GENE; GENE EXPRESSION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLUT4 GENE; HEART MUSCLE ISCHEMIA; HOMEOSTASIS; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MOLECULAR GENETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW;

EID: 54249140612     PISSN: 15612775     EISSN: 16809386     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Pessin JE, Bell GI. Mammalian facilitative glucose transporter family: structure and molecular regulation. Ann Rev Physiol 1992; 54: 911-30.
2. James DE, Brown R, Navarro J, Pilch PF. Insulin-regulatable tissues express a unique insulin-sensitive glucose transport protein. Nature 1988; 333: 183-5.
3. Berger J, Biswas C, Vicario PP, Strout HV, Saperstein R, Pilch PF. Decreased expression of the insulin-responsive glucose transporter I diabetes and fasting. Nature 1989; 340: 70-2.
4. Friedman JE, Sherman WM, Reed MJ, Elton CW, Dohm GL. Exercise training increases glucose transporter protein GLUT4 of obese Zucker (fa/fa) rats. FEBS Lett 1990; 268: 13-6.
5. Handberg A, Vaag A, Damsbo P, et al. Expression of insulin regulatable glucose transporters in skeletal muscle from type 2 diabetic patients. Diabetologia 1990; 33: 625-27.
6. Dohm GL, Elton CW, Friedman JE, Pilch PF, Pories WJ, Atkinson SM Jr, Caro JF. Decreased expression of GLUT4 in skeletal muscle from insulin-resistant patients. Am J Physiol Endocrinol Metab 1991; 260: E459-E463.
7. Eckel J, Reinauer H. Insulin action on glucose transport in cardiac myocytes: signalling pathways and diabetes induced alterations. Biochem Soc Trans 1990; 18: 1125-7.
8. Barth S, Klein W, Friehs I, Rigler B, Zechner R, Gasser R. GLUT4 mRNA expression in human myocardium is altered in patients with non-insulin-dependent diabetes mellitus. Eur Heart J 1996; 17 (Suppl): 475.
9. Brussee H, Barth S, Klein W, Friehs I, Rigler B, Gasser R. Myocardial mRNA expression of insulin-dependent transmembrane glucose transporter is increased in human insulin-dependent diabetes mellitus and decreased in non-insulin-dependent diabetes mellitus. Eur Heart J 1999; 20 (Suppl): 207.
10. Kickenweiz E, Barth S, Friehs I, Rigler B, Zechner R, Köppel H, Klein W, Gasser R. Molekulare und genetische Ursachen der Hypertonie. Jatros Kardiologie 1999; 4: 22-7.
11. Kaplan NM. Clinical hypertension. A monograph. Williams & Wilkins, Baltimore, Sydney, Tokyo, 2002.
12. Brown MJ. The causes of essential hypertension. Br J Clin Pharmacol 1996; 42: 21-7.
13. Barth S, Kickenweiz E, Friehs I, Rigler B, Zechner R, Köppel H, Gasser R. Hypertonie - Symptom oder Krankheit? J Hyperton 1999; 4: 8-15.
14. Riva-Rocci S. Un sfingomanometro nuovo. Gaz Med Torino 1896; 47: 981-96.
15. O'Shaughnessy M, Kotchen A. Epidemiologic, physiologic and clinical implications of hypertension and insulin resistance. Curr Opin Cardiol 1993; 8: 757-64.
16. Kristiansson K, Sigfusson N, Sigvaldson H, Thorgeirsson G. Glucose tolerance and blood pressure in a population-based cohort study of males and females: the Reykjavik Study. J Hypertens 1995; 13: 581-6.
17. Weidmann P, Böhlen L, de Courten M. Insulin resistance and hyperinsulinemia in hypertension. J Hypertens 1995; 13: S65-S72.
18. Gasser R. The interdependence of hypertension, calcium overload and coronary spasm in the development of myocardial infarction. Angiology 1988; 39: 761-72.
19. Atkins KB, Johns D, Watts S, Clinton Webb R, Brosius FC. Decreased vascular glucose transporter expression and glucose uptake in DOCA-salt hypertension. J Hypertens 2001; 19: 1581-7.
20. Marengo C, Macchia G, Putigna G, Accomazzo L, Pagano A, Cassader M, Disegni A, Pagano G. Hyperinsulinemia and metabolic variables in normal weight essential hypertensive patients. Nutr Metab Cardiovasc Dis 1995; 5: 211-6.
21. Nyses L, Peltzer T. Molekulare Adaptation des Herzens an Hypertonie. Z Kardiol 1995; 84 (Suppl 4): 71-6.
22. Ritter O, Neyses L. The molecular basis of myocardial hypertrophy and heart failure. Trends Mol Med 2003; 9: 313-21.
23. Katzer E, Barth S, Köppel H, Gasser R, Klein W, Friehs I, Rigler B. EGR-1 messenger RNA expression in right atrial auricle human myocardium is upregulated in hypertensive patients with myocardial hypertrophy. Proceedings World Congress of Cardiology 1998 Rio de Janeiro, Selected Papers, Monduzzi Editore Bologna; 687-92.
24. Kaczmarczyk SJ, Andrikopoulos S, Favaloro J, Domenighetti AA, Dunn A, Ernst M, Grail D, Fodero-Tavoletti M, Huggins CE, Delbridge LM, Zajac JD, Proietto J. Threshold effects of glucose transporter-4 (GLUT4) deficiency on cardiac glucose uptake and development of hypertrophy. J Mol Endocrinol 2003; 31: 449-59.
25. Paternostro G, Clarke K, Heath J, Seymour AM, Radd GK. Decreased GLUT4 mRNA content and insulin-sensitive deoxyglucose uptake show insulin resistance in the hypertensive rat heart. Cardiovasc Res 1995; 30: 205-11.
26. th Alpe Adria Cardiology Meeting Grado, 1996, Abstract book.
27. Schwaiger M, Sun D, Deed GM, Nguyen N, Haas F. Expression of myocardial glucose transporter (GLUT) mRNAs with advanced coronary heart disease (CAD). Circulation 1994; 90 (Suppl I): 113.
28. Garvey WT, Hardin D, Juhaszova M, Dominguez JH. Effects of diabetes on myocardial glucose transport system in rats: implications for diabetic cardiomyopathy. Am J Physiol 1993; 264: H837-H844.
29. Campbell IW, Dominiczak AF, Livingstone C, Gould GW. Analysis of the glucose transporter compliment of metabolically important tissues from the Milan hypertensive rat. Biochem Biophys Res Commun 1995; 211: 780-91.
30. Ikegami H, Yamato E, Fujisawa T, Hamada Y, Fujioka Y, Rakugi H, Higaki J, Murakami H, Shimamoto K, Ogihara T. Analysis of candidate genes for insulin resistance in essential hypertension. Hypertens Res 1996; 19 (Suppl 1): S31-S34.
31. Gasser R, Klein W. Katp-channels, action potential shortening and contractile failure in early myocardial ischemia, a review (invited paper). Cardiovasc Drugs Ther 1994; 8: 813-22.
32. Gasser R, Vaughan-Jones RD. Mechanism of potassium efflux and action potential shortening during ischemia in isolated mammalian cardiac muscle. J Physiol (London) 1990; 431: 713-41.
33. Tong H, Chen W, London RE, Murphy E, Steenbergen C. Preconditioning enhanced glucose uptake is mediated by p38 MAP kinase not by phosphatidylinositol 3-kinase. J Biol Chem 2000; 275: 11981-6.
34. Tian R, Abel ED. Responses of GLUT4 deficient hearts to ischemia underscore importance of glycolysis. Circulation 2001; 103: 2961-6.
35. Egert S, Nguyen N, Schwaiger M. Myocardial glucose transporter GLUT1: translocation induced by insulin and ischemia. J Mol Cell Cardiol 1999; 31: 1337-44.
36. Egert S, Nguyen N, Schwaiger M. Contribution of alpha-adrenergic and beta-adrenergic stimulation to ischemia-induced glucose transporter (GLUT) and GLUT1 translocation in the isolated perfused rat heart. Circul Res 1999; 84: 1407-15.
37. Russell RR, YIN R, Caplan MJ, Hu X, Ren J, Shulman GI, Sinusas AJ, Young LH. Additive effects of hyperinsulinemia and ischemia on myocardial GLUT1 and GLUT4 translocation in vivo. Circulation 1998; 98: 2180-6.
38. King LM, Opie LH. Glucose delivery is a major determinant of glucose utilisation in the ischemic myocardium with a residual coronary flow. Cardiovasc Res 1998; 39: 381-92.
39. rd, Nguyen N, Egert S, Lin Z, Deeb GM, Haas F, Schwaiger M, Sun D. Increased sarcolemmal glucose transporter abundance in myocardial ischemia. Am J Cardiol 1997; 80: 77A-84A.